These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19011457)

  • 1. Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination.
    Coskun M; Zoroglu S
    J Clin Psychopharmacol; 2008 Dec; 28(6):723-5. PubMed ID: 19011457
    [No Abstract]   [Full Text] [Related]  

  • 2. Tactile hallucinations with fluoxetine and methylphenidate.
    Arora GS; Arora HK; Sidhu J; Najjar F
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):360-1. PubMed ID: 25007312
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylphenidate-induced visual hallucinations.
    Porfirio MC; Giana G; Giovinazzo S; Curatolo P
    Neuropediatrics; 2011 Feb; 42(1):30-1. PubMed ID: 21500140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual Hallucinations with Methylphenidate and Acetaminophen in Combination.
    Hergüner S; Özayhan HY
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):598-9. PubMed ID: 26222326
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylphenidate and somatic hallucinations.
    Rashid J; Mitelman S
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):945-946. PubMed ID: 17667474
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hallucinations caused by the introduction of methylphenidate at low doses].
    Aguilera-Albesa S; Yoldi-Petri ME; Molins-Castiella T; Durá-Travé T
    Rev Neurol; 2010 Aug; 51(4):254-5. PubMed ID: 20648469
    [No Abstract]   [Full Text] [Related]  

  • 7. Abuse and toxicity of methylphenidate.
    Klein-Schwartz W
    Curr Opin Pediatr; 2002 Apr; 14(2):219-23. PubMed ID: 11981294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression:
    Kim C; Lee DY; Park J; Yang SJ; Tan EH; Alhambra DP; Lee YH; Lee S; Kim SJ; Lee J; Park RW; Shin Y
    Psychol Med; 2023 Jul; 53(10):4811-4819. PubMed ID: 36803587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive masturbation and hypersexual behavior associated with methylphenidate.
    Bilgiç A; Gürkan K; Türkoğlu S
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
    [No Abstract]   [Full Text] [Related]  

  • 10. Methylphenidate induction of complex visual hallucinations.
    Halevy A; Shuper A
    J Child Neurol; 2009 Aug; 24(8):1005-7. PubMed ID: 19502578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Raynaud phenomenon as adverse effect of ADHD treatment].
    Lakartidningen; 2008 Dec 10-16; 105(50):3662-3. PubMed ID: 19177933
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of adult ADHD and comorbid disorders.
    Young JL
    CNS Spectr; 2006 Oct; 11(10 Suppl 11):10-2. PubMed ID: 17712918
    [No Abstract]   [Full Text] [Related]  

  • 14. Pregnancy and delivery complications and treatment approach in attention deficit hyperactivity disorder.
    Aktepe E; Ozkorumak E; Tanriöver-Kandil S
    Turk J Pediatr; 2009; 51(5):478-84. PubMed ID: 20112604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Visual hallucinations caused by methylphenidate].
    Tomás Vila M; Izquierdo Quevedo FJ; Cerdán Vera MT; Fernández A; Artés Figueres M; Revert Gomas M
    An Pediatr (Barc); 2010 Mar; 72(3):229-30. PubMed ID: 20097145
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical perspectives: combined pharmacotherapy.
    O'Malley KD
    J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1558-9. PubMed ID: 8543526
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylphenidate euphoria.
    Corrigall R; Ford T
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
    [No Abstract]   [Full Text] [Related]  

  • 18. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate transdermal system in attention-deficit hyperactivity disorder in children: A viewpoint by Raul R. Silva.
    Silva RR
    Drugs; 2006; 66(8):1127-8; discussion 1128. PubMed ID: 16789798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.